Porcine Reproductive and Respiratory Syndrome Virus: Challenges and Advances in Vaccine Development
Top Cited Papers
Open Access
Abstract
Persistent infection of porcine reproductive and respiratory syndrome virus (PRRSV) significantly hampers both the quantity and quality of pork production in China. Although PRRSV is widely prevalent worldwide, the absence of effective vaccines has made it one of the major pathogens threatening the sustainable development of the global swine industry. Vaccination remains one of the most effective measures for controlling pathogen infections. However, the continuous genetic recombination and mutation of PRRSV demand more comprehensive strategies to address emerging threats, while ensuring the efficacy and safety of vaccines. This review provides an overview of the latest advances in PRRSV vaccine research, highlighting the importance of understanding the unique strengths and limitations of various vaccines in developing effective therapeutic approaches and vaccination strategies. Moreover, the development of adjuvants and antiviral drugs as adjuncts to combat PRRSV infection offers significant potential for enhancing disease control efforts. With the advancement of technologies such as proteolysis-targeting chimera (PROTAC) and mRNA, new avenues for controlling PRRSV and other pathogens are emerging, offering considerable hope. Ultimately, the goal of these vaccine developments is to alleviate the impact of PRRSV on animal health and the profitability of the swine industry.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFD1801500, 2024A1515012991, 2023B03J0947, 2025D04J0072, WS-HN-ZYZL-202406-208)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023YFD1801500, 2024A1515012991, 2023B03J0947, 2025D04J0072, WS-HN-ZYZL-202406-208)
- Science and Technology Planning Project of Guangzhou (2023YFD1801500, 2024A1515012991, 2023B03J0947, 2025D04J0072, WS-HN-ZYZL-202406-208)
- SCAU & Wens Science and Technology Innovation Center Project (2023YFD1801500, 2024A1515012991, 2023B03J0947, 2025D04J0072, WS-HN-ZYZL-202406-208)
This publication has 135 references indexed in Scilit:
- Phylogeographic analysis of porcine reproductive and respiratory syndrome virus 1 in Guangdong province, Southern ChinaArchives of Virology, 2018
- Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigsPlanta, 2018
- Genetic diversity and evolutionary characteristics of type 2 porcine reproductive and respiratory syndrome virus in southeastern China from 2009 to 2014Archives of Virology, 2017
- Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and ChallengesStem Cells, 2016
- Intracellularly expressed nanobodies against non-structural protein 4 of porcine reproductive and respiratory syndrome virus inhibit virus replicationBiotechnology Letters, 2016
- Plant‐derived pharmaceuticals for the developing worldBiotechnology Journal, 2013
- Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid ABAntiviral Research, 2013
- RNA immunization can protect mice against foot-and-mouth disease virusAntiviral Research, 2010
- Categorization of North American porcine reproductive and respiratory syndrome viruses: Epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralizationArchives of Virology, 2000
- Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2Research in Veterinary Science, 1993